Characterization of drug-related problems and associated factors in ambulatory patients in China.

Journal of Clinical Pharmacy and Therapeutics
Xin WangLihong Liu

Abstract

This study aimed to investigate the prevalence and the type of drug-related problems (DRPs) in ambulatory patients and identify factors that may be associated with risk of DRPs. Consecutive patients were enrolled from pharmacist outpatient clinics between January 2018 and June 2019. The pharmacists performed a comprehensive assessment of the patient's drug therapy. The DRPs and recommendations were evaluated using the DOCUMENT classification system. The study population consisted of 248 patients with a mean age of 72.55 ± 6.29. The patients had a mean of 7.55 ± 4.72 ongoing medications during patients' routine clinic visits. A total of 1188 DRPs were identified during the study period. An average of 4.79 DRPs per patient was detected. Sixty-two different traditional Chinese patent medicines (TCPMs) contributed to 102 DRPs. Drug selection (24.9%) was the most common DRP followed by under treated (24.2%) and monitoring needed (24.2%). The number of medications taken was the significant factor for DRPs. Pharmacists made 1092 recommendations to address the DRPs (an average 0.92 recommendations per DRP). A change in therapy was the most common recommendation (43.6%), followed by the category 'monitoring' (28.6%). The overall accepta...Continue Reading

References

Aug 31, 2006·British Journal of Clinical Pharmacology·Kirsten K ViktilAasmund Reikvam
Sep 18, 2007·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Kristina Johnell, Inga Klarin
Jan 1, 1949·American Journal of Public Health and the Nation's Health·W T FALES, I M MORIYAMA
Jan 9, 2008·The American Journal of Geriatric Pharmacotherapy·Emily R HajjarJoseph T Hanlon
Feb 27, 2009·Pharmacy World & Science : PWS·Andrew C StaffordMette Rasmussen
May 19, 2010·Ageing Research Reviews·Sven StegemannBianca Broegmann
Mar 1, 2011·Archives of Gerontology and Geriatrics·Ding-Cheng ChanShwu-Chong Wu
Nov 22, 2011·International Journal of Clinical Pharmacy·Mackenzie WilliamsAndrew C Stafford
Dec 31, 2011·International Journal of Clinical Pharmacy·Patrik MidlövTommy Eriksson
Mar 6, 2012·The American Journal of Geriatric Pharmacotherapy·Timothy ReillyStanley Reuben
Aug 28, 2012·European Heart Journal·UNKNOWN Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)Doron Zahger
Nov 13, 2012·Journal of Cardiopulmonary Rehabilitation and Prevention·M Wasem AlsabbaghDavid F Blackburn
Jan 1, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Fabio SalviAntonio Cherubini
Oct 1, 2013·Current Opinion in Nephrology and Hypertension·Wendy L St PeterUptal D Patel
Feb 18, 2014·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Ding-Cheng ChanShwu-Chong Wu
Jan 18, 2016·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Wan-Tseng HsuChii-Ming Lee
Aug 25, 2016·International Journal of Cardiology·Alberto Ruano-RavinaJose Ramón González-Juanatey
Dec 1, 2017·International Journal of Clinical Pharmacy·Mounir RhalimiEric Housieaux

❮ Previous
Next ❯

Citations

Apr 14, 2021·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Xincai ZhaoJianping Zhang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.